Literature DB >> 10336129

Alpha2C-adrenoceptor overexpression disrupts execution of spatial and non-spatial search patterns.

M Björklund1, J Sirviö, J Sallinen, M Scheinin, B K Kobilka, P Riekkinen.   

Abstract

We investigated the role of alpha2C-adrenoceptors in the modulation of spatial and non-spatial navigation behaviour. Alpha2C-adrenoceptor overexpressing mice developed an ineffective thigmotaxic search pattern characterized by swimming close to the pool walls during both spatial and non-spatial water maze training. A subtype-non-selective alpha2-adrenoceptor antagonist, atipamezole (1000 microg/kg, s.c.), fully reversed this impairment in their search strategy. Withdrawal of atipamezole at the end of spatial training resulted in an immediate disruption of the search pattern in alpha2C-adrenoceptor overexpressing mice. The swimming pattern of alpha2C-adrenoceptor overexpressing mice during a five day free swimming period was normal, when no cognitive component was required. Diazepam (0.3 and 1.0 mg/kg, i.p.), neither improved the accuracy in finding the platform nor decreased thigmotaxis. These results suggest that alpha2C-adrenoceptors may modulate the execution of complex navigation patterns.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10336129     DOI: 10.1016/s0306-4522(98)00306-6

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  6 in total

1.  In vivo evaluation of limiting brain penetration of probes for α(2C)-adrenoceptor using small-animal positron emission tomography.

Authors:  Kazunori Kawamura; Megumi Akiyama; Joji Yui; Tomoteru Yamasaki; Akiko Hatori; Katsushi Kumata; Hidekatsu Wakizaka; Makoto Takei; Nobuki Nengaki; Kazuhiko Yanamoto; Toshimitsu Fukumura; Ming-Rong Zhang
Journal:  ACS Chem Neurosci       Date:  2010-06-02       Impact factor: 4.418

2.  JP-1302: a new tool to shed light on the roles of alpha2C-adrenoceptors in brain.

Authors:  M D Tricklebank
Journal:  Br J Pharmacol       Date:  2007-01-15       Impact factor: 8.739

3.  Effects of variation in the human alpha2A- and alpha2C-adrenoceptor genes on cognitive tasks and pain perception.

Authors:  Utkarsh Kohli; Mordechai Muszkat; Gbenga G Sofowora; Paul A Harris; Eitan A Friedman; William D Dupont; Mika Scheinin; Alastair J J Wood; C Michael Stein; Daniel Kurnik
Journal:  Eur J Pain       Date:  2009-05-06       Impact factor: 3.931

Review 4.  Upcoming agents for the treatment of schizophrenia: mechanism of action, efficacy and tolerability.

Authors:  Delia Bishara; David Taylor
Journal:  Drugs       Date:  2008       Impact factor: 9.546

5.  Noradrenaline and Movement Initiation Disorders in Parkinson's Disease: A Pharmacological Functional MRI Study with Clonidine.

Authors:  Marion Criaud; Chloé Laurencin; Alice Poisson; Elise Metereau; Jérôme Redouté; Stéphane Thobois; Philippe Boulinguez; Bénédicte Ballanger
Journal:  Cells       Date:  2022-08-25       Impact factor: 7.666

Review 6.  Therapeutic Potential of Selectively Targeting the α2C-Adrenoceptor in Cognition, Depression, and Schizophrenia-New Developments and Future Perspective.

Authors:  Madeleine Monique Uys; Mohammed Shahid; Brian Herbert Harvey
Journal:  Front Psychiatry       Date:  2017-08-14       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.